Cardiovascular disease and cancer: shared risk factors and mechanisms
Open accessThe DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Abstract
Cardiovascular disease (CVD) and cancer are among the leading causes of morbidity and mortality globally, and these conditions are increasingly recognized to be fundamentally interconnected. In this Review, we present the current epidemiological data for each of the modifiable risk factors shared by the two diseases, including hypertension, hyperlipidaemia, diabetes mellitus, obesity, smoking, diet, physical activity and the social determinants of health. We then review the epidemiological data demonstrating the increased risk of CVD in patients with cancer, as well as the increased risk of cancer in patients with CVD. We also discuss the shared mechanisms implicated in the development of these conditions, highlighting their inherent bidirectional relationship. We conclude with a perspective on future research directions for the field of cardio-oncology to advance the care of patients with CVD and cancer. Patients with cardiovascular disease (CVD) have an increased risk of cancer, and patients with cancer have an increased risk of CVD. In this Review, the authors discuss the shared modifiable risk factors and the shared pathophysiological mechanisms underlying the bidirectional relationship between these two prevalent diseases. Cardiovascular disease (CVD) and cancer have a bidirectional relationship, with shared mechanisms and risk factors that predispose individuals to both disease states. Shared modifiable risk factors for CVD and cancer include hypertension, diabetes mellitus, obesity, smoking, diet, physical activity and social determinants of health. Patients with cancer are at increased risk of multiple CVD subtypes, as well as death from CVD, owing at least in part to the development of shared modifiable risk factors. Patients with CVD are at increased risk of multiple cancer subtypes and cancer-related death, although variation exists among studies and among types of cancer. Shared mechanisms underlying both CVD and cancer include chronic inflammation, oxidative stress, metabolic dysregulation, clonal haematopoiesis of indeterminate potential, microbial dysbiosis, hormonal effects and cell senescence. Understanding the risk factors and mechanisms shared between CVD and cancer enables the prediction, prevention and treatment of both, which is necessary to advance the field of cardio-oncology. Cardiovascular disease (CVD) and cancer have a bidirectional relationship, with shared mechanisms and risk factors that predispose individuals to both disease states. Shared modifiable risk factors for CVD and cancer include hypertension, diabetes mellitus, obesity, smoking, diet, physical activity and social determinants of health. Patients with cancer are at increased risk of multiple CVD subtypes, as well as death from CVD, owing at least in part to the development of shared modifiable risk factors. Patients with CVD are at increased risk of multiple cancer subtypes and cancer-related death, although variation exists among studies and among types of cancer. Shared mechanisms underlying both CVD and cancer include chronic inflammation, oxidative stress, metabolic dysregulation, clonal haematopoiesis of indeterminate potential, microbial dysbiosis, hormonal effects and cell senescence. Understanding the risk factors and mechanisms shared between CVD and cancer enables the prediction, prevention and treatment of both, which is necessary to advance the field of cardio-oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266 · cited 1×
“In a meta-analysis of 61 prospective cohort studies in one million adults without prior CVD, a twofold increase in death from stroke and ischaemic heart disease (IHD) was found for a 20 mmHg increase in usual systolic blood pressure (SBP) in those aged 40–69 years 30 .”
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915 · cited 2×
“Chronic systemic inflammation leads to impaired immune function and, therefore, increased susceptibility to various non-communicable diseases, including CVD and cancer 139 .”
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · cited 1×
“Individuals with CHIP are at increased risk of developing a haematological neoplasm (0.5–1.0% per year versus 0.1% in those without CHIP), and mortality is increased by 40%, which is not explained by progression to myelodysplastic syndromes or leukaemia, but rather by CAD and ischaemic stroke 160 .”
InfluentialArnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755 · cited 1×
“Reductions in blood pressure are also associated with decreased all-cause mortality (relative risk (RR) 0.87, 95% CI 0.84–0.91) 32 .”
InfluentialObesity and cardiovascular disease: a scientific statement from the American Heart Association
Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000973 · Cited by 3,691
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690 · cited 1×
“Chronic inflammation is age-related and occurs due to biological, psychosocial and environmental factors that lead to persistent, low-grade, systemic upregulation of inflammatory activity 138 .”
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800389 · Cited by 3,616 · cited 1×
“In a multicentre RCT conducted in Spain, 7,447 participants at high risk of CVD were assigned to either a Mediterranean diet, supplemented with either olive oil or mixed nuts, or to a low-fat diet (control group) 81 ) 85 .”
Kodama, S. (2009) · JAMA · doi:10.1001/jama.2009.681 · Cited by 3,035
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900 · cited 2×
“…of ROS — particularly the superoxide anion, the hydroxyl radical and hydrogen peroxide — overwhelm endogenous antioxidant capacity, leading to the oxidation of macromolecules and aberrant redox signalling, telomere shortening, mitochondrial dysfunction and consequent cellular injury 150,151 .”
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683 · cited 1×
“CHIP carriers with a VAF of >10% are at increased risk of CAD (HR 12.0, 95% CI 2.4–64.0), and the JAK2 V617F mutation is associated with the highest risk of MI (HR 12.0, 95% CI 3.8–38.4) 161 .”
InfluentialNF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679 · cited 1×
“For example, activation of nuclear factor-κB and signal transducer and activator of transcription 3, which are key inflammatory transcription factors, is known to promote cancer cell proliferation, survival and metastasis, and is associated with an increased risk of diverse cancer subtypes 147 .”
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654 · cited 1×
“…modulate sulfur-based metabolism, NADPH production and generate antioxidant transcription factors, such as nuclear factor erythroid 2-related factor 2, and their associated targets to maintain sufficient levels of ROS to promote tumorigenesis but avoid apoptosis, autophagy and necroptosis 152,153 .”
The ever‐increasing importance of cancer as a leading cause of premature death worldwide
Bray, F., Laversanne, M., Weiderpass, E., & Soerjomataram, I. (2021) · Cancer · doi:10.1002/cncr.33587 · Cited by 2,591
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570 · cited 2×
“Chronic systemic inflammation also increases the risk of hypertension, hyperlipidaemia and type 2 diabetes, which as detailed above, are established risk factors for CVD 143,144 .”
(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 2×
“This association was observed for both sexes and across all age groups investigated, including ages 40–49 years (adjusted HR 0.44, 95% CI 0.42–0.48), ages 50–69 years (adjusted HR 0.66, 95% CI 0.65–0.68) and ages 70–89 years (adjusted HR 0.83, 95% CI 0.81–0.85) 38 .”
InfluentialEinarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0728-6 · Cited by 2,312 · cited 1×
“In a systematic review of 57 studies including more than 4.5 million adults with type 2 diabetes, 50.3% of all deaths were attributed to CVD 55,56 .”
InfluentialROS in cancer therapy: the bright side of the moon
Perillo, B., Di Donato, M., Pezone, A., Di Zazzo, E., Giovannelli, P., Galasso, G., Castoria, G., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0384-2 · Cited by 2,176
High blood pressure and cardiovascular disease
Fuchs, F. D., & Whelton, P. K. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14240 · Cited by 1,948 · cited 1×
“Hypertension is an important causative risk factor for the development of CVD, as demonstrated by numerous prospective cohort studies, randomized clinical trials (RCTs) and meta-analyses 28 (Table 2).”
Bhaskaran, K., Douglas, I., Forbes, H., dos-Santos-Silva, I., Leon, D. A., & Smeeth, L. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60892-8 · Cited by 1,707
Gut microbiota in cardiovascular health and disease
Tang, W. H. W., Kitai, T., & Hazen, S. L. (2017) · Circulation Research · doi:10.1161/circresaha.117.309715 · Cited by 1,670
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Shared Risk Factors in Cardiovascular Disease and Cancer
Koene, R. J., Prizment, A. E., Blaes, A., & Konety, S. H. (2016) · Circulation · doi:10.1161/circulationaha.115.020406 · Cited by 1,494
Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults
Moore, S. C., Lee, I.-M., Weiderpass, E., Campbell, P. T., Sampson, J. N., Kitahara, C. M., Keadle, S. K., Arem, H., Berrington de Gonzalez, A., Hartge, P., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.1548 · Cited by 1,487
Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis
Bagnardi, V, Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V, Scotti, L., Jenab, M., Turati, F., Pasquali, E., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.579 · Cited by 1,342 · cited 1×
“…with cancer across 572 studies, alcohol consumption was associated with a dose-dependent increased risk of oropharyngeal, oesophageal, colorectal, laryngeal and breast cancers 75 , and an increased risk of various other types of cancer has been observed with heavy drinking (>60 g per day) 76,77 .”
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B.-S., Kroemer, G., & Galluzzi, L. (2018) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,273
Development and validation of the American Heart Association’s PREVENT equations
Khan, S. S., Matsushita, K., Sang, Y., Ballew, S. H., Grams, M. E., Surapaneni, A., Blaha, M. J., Carson, A. P., Chang, A. R., Ciemins, E., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067626 · Cited by 1,234
Leon, B. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i13.1246 · Cited by 1,215 · cited 1×
“In a systematic review of 57 studies including more than 4.5 million adults with type 2 diabetes, 50.3% of all deaths were attributed to CVD 55,56 .”
InfluentialWood, A. M., Kaptoge, S., Butterworth, A. S., Willeit, P., Warnakula, S., Bolton, T., Paige, E., Paul, D. S., Sweeting, M., Burgess, S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30134-x · Cited by 1,188 · cited 1×
“An analysis of 83 prospective studies including nearly 600,000 current drinkers across 19 countries demonstrated a positive association between increased alcohol consumption and multiple CVD subtypes 74 .”
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
The Reasons for Geographic and Racial Differences in Stroke Study: Objectives and Design
Howard, V. J., Cushman, M., Pulley, L., Gomez, C. R., Go, R. C., Prineas, R. J., Graham, A., Moy, C. S., & Howard, G. (2005) · Neuroepidemiology · doi:10.1159/000086678 · Cited by 1,175
Clonal hematopoiesis in human aging and disease
Jaiswal, S., & Ebert, B. L. (2019) · Science · doi:10.1126/science.aan4673 · Cited by 1,156 · cited 1×
“Macrophages carrying TET2 mutations have been shown to overexpress IL-6, IL-1β and IL-8, which leads to increased chemotaxis to plaques and accelerated atherosclerosis 159 .”
Cellular senescence: the good, the bad and the unknown
Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L., & Lerman, L. O. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00601-z · Cited by 1,150
Hyperlipidemia as a Risk Factor for Cardiovascular Disease
Nelson, R. H. (2013) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2012.11.003 · Cited by 1,093
Rahimi, K., Bidel, Z., Nazarzadeh, M., Copland, E., Canoy, D., Ramakrishnan, R., Pinho-Gomes, A.-C., Woodward, M., Adler, A., Agodoa, L., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00590-0 · Cited by 1,074
Dose Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis
Sattelmair, J., Pertman, J., Ding, E. L., Kohl, H. W., Haskell, W., & Lee, I.-M. (2011) · Circulation · doi:10.1161/circulationaha.110.010710 · Cited by 1,052 · cited 1×
“Several large meta-analyses have demonstrated a dose-dependent, positive association between increased leisure time and occupational physical activity with a reduced risk of CVD compared with low levels or no physical activity 95,96 .”
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Physical activity in cancer prevention and survival: A systematic review
MCTIERNAN, A., FRIEDENREICH, C. M., KATZMARZYK, P. T., POWELL, K. E., MACKO, R., BUCHNER, D., PESCATELLO, L. S., BLOODGOOD, B., TENNANT, B., VAUX-BJERKE, A., et al. (2019) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001937 · Cited by 1,023
Targeting inflammation in atherosclerosis — from experimental insights to the clinic
Soehnlein, O., & Libby, P. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00198-1 · Cited by 1,019
Tobacco smoking and cancer: A meta‐analysis
Gandini, S., Botteri, E., Iodice, S., Boniol, M., Lowenfels, A. B., Maisonneuve, P., & Boyle, P. (2008) · International Journal of Cancer · doi:10.1002/ijc.23033 · Cited by 971
Mitochondrial dysfunction and oxidative stress in heart disease
Peoples, J. N., Saraf, A., Ghazal, N., Pham, T. T., & Kwong, J. Q. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0355-7 · Cited by 950
A population-based study of cardiovascular disease mortality risk in US cancer patients
Sturgeon, K. M., Deng, L., Bluethmann, S. M., Zhou, S., Trifiletti, D. M., Jiang, C., Kelly, S. P., & Zaorsky, N. G. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz766 · Cited by 923
The Mediterranean Diet and Cardiovascular Health: A Critical Review
Martínez-González, M. A., Gea, A., & Ruiz-Canela, M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313348 · Cited by 878
Coombs, C. C., Zehir, A., Devlin, S. M., Kishtagari, A., Syed, A., Jonsson, P., Hyman, D. M., Solit, D. B., Robson, M. E., Baselga, J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.07.010 · Cited by 866
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 860
Social Determinants of Cardiovascular Disease
Powell-Wiley, T. M., Baumer, Y., Baah, F. O., Baez, A. S., Farmer, N., Mahlobo, C. T., Pita, M. A., Potharaju, K. A., Tamura, K., & Wallen, G. R. (2022) · Circulation Research · doi:10.1161/circresaha.121.319811 · Cited by 844
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Kyrgiou, M., Kalliala, I., Markozannes, G., Gunter, M. J., Paraskevaidis, E., Gabra, H., Martin-Hirsch, P., & Tsilidis, K. K. (2017) · BMJ · doi:10.1136/bmj.j477 · Cited by 803 · cited 1×
“…of 95 meta-analyses revealed significant associations between various markers of adiposity, including BMI, waist-to-hip ratio and weight gain, and 11 distinct malignancies, including hormone-related cancers, multiple myeloma, kidney cancer and various cancers of the gastrointestinal system 52 .”
Senescence and cancer — role and therapeutic opportunities
Schmitt, C. A., Wang, B., & Demaria, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00668-4 · Cited by 794 · cited 1×
“Chronic systemic inflammation has a central role in the pathogenesis of CVD and cancer 135–137 .”
Cai, X., Zhang, Y., Li, M., Wu, J. H., Mai, L., Li, J., Yang, Y., Hu, Y., & Huang, Y. (2020) · BMJ · doi:10.1136/bmj.m2297 · Cited by 749
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Herrmann, J. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0348-1 · Cited by 747
Gut microbiota in colorectal cancer development and therapy
Wong, C. C., & Yu, J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00766-x · Cited by 721
Wahid, A., Manek, N., Nichols, M., Kelly, P., Foster, C., Webster, P., Kaur, A., Friedemann Smith, C., Wilkins, E., Rayner, M., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002495 · Cited by 715 · cited 1×
“…demonstrated that an increase in physical activity (from inactivity to recommended levels: 150 min of moderate-intensity aerobic activity per week) was associated with a significant reduction in both the incidence of CVD (RR 0.83, 95% CI 0.77–0.89) and CVD mortality (RR 0.77, 95% CI 0.71–0.84) 97 .”
InfluentialBechthold, A., Boeing, H., Schwedhelm, C., Hoffmann, G., Knüppel, S., Iqbal, K., De Henauw, S., Michels, N., Devleesschauwer, B., Schlesinger, S., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1392288 · Cited by 693 · cited 2×
“Conversely, consuming processed meats, red meats and sugar-sweetened beverages increased the risk of CVD (RR range 1.06–1.15 per daily serving change for harmful associations) 86,87 .”
InfluentialGlobal burden of cancer in 2020 attributable to alcohol consumption: a population-based study
Rumgay, H., Shield, K., Charvat, H., Ferrari, P., Sornpaisarn, B., Obot, I., Islami, F., Lemmens, V. E. P. P., Rehm, J., & Soerjomataram, I. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00279-5 · Cited by 683
Physical activity and risk of cardiovascular disease—a meta-analysis of prospective cohort studies
Li, J., & Siegrist, J. (2012) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph9020391 · Cited by 674 · cited 1×
“Several large meta-analyses have demonstrated a dose-dependent, positive association between increased leisure time and occupational physical activity with a reduced risk of CVD compared with low levels or no physical activity 95,96 .”
Causes of death among cancer patients
Zaorsky, N. G., Churilla, T. M., Egleston, B. L., Fisher, S. G., Ridge, J. A., Horwitz, E. M., & Meyer, J. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw604 · Cited by 657
Hackshaw, A., Morris, J. K., Boniface, S., Tang, J.-L., & Milenković, D. (2018) · BMJ · doi:10.1136/bmj.j5855 · Cited by 645
Adherence to Mediterranean Diet and Risk of Cancer: An Updated Systematic Review and Meta-Analysis
Schwingshackl, L., Schwedhelm, C., Galbete, C., & Hoffmann, G. (2017) · Nutrients · doi:10.3390/nu9101063 · Cited by 632
Impact of Oxidative Stress on the Heart and Vasculature
Münzel, T., Camici, G. G., Maack, C., Bonetti, N. R., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.035 · Cited by 619
Host variables confound gut microbiota studies of human disease
Vujkovic-Cvijin, I., Sklar, J., Jiang, L., Natarajan, L., Knight, R., & Belkaid, Y. (2020) · Nature · doi:10.1038/s41586-020-2881-9 · Cited by 614
Diabetes Mellitus–Related All‐Cause and Cardiovascular Mortality in a National Cohort of Adults
Raghavan, S., Vassy, J. L., Ho, Y., Song, R. J., Gagnon, D. R., Cho, K., Wilson, P. W. F., & Phillips, L. S. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011295 · Cited by 563
Navarese, E. P., Robinson, J. G., Kowalewski, M., Kolodziejczak, M., Andreotti, F., Bliden, K., Tantry, U., Kubica, J., Raggi, P., & Gurbel, P. A. (2018) · JAMA · doi:10.1001/jama.2018.2525 · Cited by 549 · cited 2×
“…level ≥100 mg/dl, more intensive lipid-lowering therapy (statins, ezetimibe and proprotein convertase subtilisin/kexin type 9 inhibitors) was associated with greater reduction in cardiovascular mortality and all-cause mortality, with a greater effect at higher baseline LDL cholesterol levels 39 .”
InfluentialPetrelli, F., Cortellini, A., Indini, A., Tomasello, G., Ghidini, M., Nigro, O., Salati, M., Dottorini, L., Iaculli, A., Varricchio, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.3520 · Cited by 530 · cited 1×
“19) in patients with breast, colorectal, prostate and gastro-oesophageal cancers 54 .”
The Impact of Obesity on the Cardiovascular System
Csige, I., Ujvárosy, D., Szabó, Z., Lőrincz, I., Paragh, G., Harangi, M., & Somodi, S. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3407306 · Cited by 500
Targeting the gut and tumor microbiota in cancer
Park, E. M., Chelvanambi, M., Bhutiani, N., Kroemer, G., Zitvogel, L., & Wargo, J. A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01779-2 · Cited by 496 · cited 1×
“Microbial dysbiosis, which refers to alterations in the gut microbiome and its metabolites, is recognized as a driver of both CVD and cancer and is influenced in part by modifiable environmental factors, including diet and medication 164–166 .”
Grosso, G., Marventano, S., Yang, J., Micek, A., Pajak, A., Scalfi, L., Galvano, F., & Kales, S. N. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1107021 · Cited by 456
Physical Activity and Mortality in Cancer Survivors: A Systematic Review and Meta-Analysis
Friedenreich, C. M., Stone, C. R., Cheung, W. Y., & Hayes, S. C. (2020) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz080 · Cited by 453
Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease
Biddinger, K. J., Emdin, C. A., Haas, M. E., Wang, M., Hindy, G., Ellinor, P. T., Kathiresan, S., Khera, A. V., & Aragam, K. G. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.3849 · Cited by 445
Kim, H., Caulfield, L. E., Garcia‐Larsen, V., Steffen, L. M., Coresh, J., & Rebholz, C. M. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012865 · Cited by 437
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
Engelen, S. E., Robinson, A. J. B., Zurke, Y.-X., & Monaco, C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00668-4 · Cited by 425
Light alcohol drinking and cancer: a meta-analysis
Bagnardi, V., Rota, M., Botteri, E., Tramacere, I., Islami, F., Fedirko, V., Scotti, L., Jenab, M., Turati, F., Pasquali, E., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds337 · Cited by 424
Trøseid, M., Andersen, G. Ø., Broch, K., & Hov, J. R. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102649 · Cited by 408
Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease
Duncan, M. S., Freiberg, M. S., Greevy, R. A., Kundu, S., Vasan, R. S., & Tindle, H. A. (2019) · JAMA · doi:10.1001/jama.2019.10298 · Cited by 398
Heart Failure Stimulates Tumor Growth by Circulating Factors
Meijers, W. C., Maglione, M., Bakker, S. J. L., Oberhuber, R., Kieneker, L. M., de Jong, S., Haubner, B. J., Nagengast, W. B., Lyon, A. R., van der Vegt, B., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030816 · Cited by 385
Kim, M. S., Kim, W. J., Khera, A. V., Kim, J. Y., Yon, D. K., Lee, S. W., Shin, J. I., & Won, H.-H. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab454 · Cited by 378
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Zhao, L.-Y., Mei, J.-X., Yu, G., Lei, L., Zhang, W.-H., Liu, K., Chen, X.-L., Kołat, D., Yang, K., & Hu, J.-K. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01406-7 · Cited by 359
An updated systematic review and meta-analysis on adherence to mediterranean diet and risk of cancer
Morze, J., Danielewicz, A., Przybyłowicz, K., Zeng, H., Hoffmann, G., & Schwingshackl, L. (2021) · European Journal of Nutrition · doi:10.1007/s00394-020-02346-6 · Cited by 352
Pan, A., Wang, Y., Talaei, M., & Hu, F. B. (2015) · Circulation · doi:10.1161/circulationaha.115.017926 · Cited by 343
Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis
O’Keeffe, L. M., Taylor, G., Huxley, R. R., Mitchell, P., Woodward, M., & Peters, S. A. E. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021611 · Cited by 332
Banks, E., Joshy, G., Korda, R. J., Stavreski, B., Soga, K., Egger, S., Day, C., Clarke, N. E., Lewington, S., & Lopez, A. D. (2019) · BMC Medicine · doi:10.1186/s12916-019-1351-4 · Cited by 319
Cardiovascular Disease Risk Among Cancer Survivors
Florido, R., Daya, N. R., Ndumele, C. E., Koton, S., Russell, S. D., Prizment, A., Blumenthal, R. S., Matsushita, K., Mok, Y., Felix, A. S., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.04.042 · Cited by 319
Larsson, S. C., & Burgess, S. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104154 · Cited by 315
Common risk factors for heart failure and cancer
Meijers, W. C., & de Boer, R. A. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz035 · Cited by 314
The role of cellular senescence in cardiac disease: basic biology and clinical relevance
Mehdizadeh, M., Aguilar, M., Thorin, E., Ferbeyre, G., & Nattel, S. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00624-2 · Cited by 304
Marnell, C. S., Bick, A., & Natarajan, P. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.07.004 · Cited by 289
Meacham, L. R., Chow, E. J., Ness, K. K., Kamdar, K. Y., Chen, Y., Yasui, Y., Oeffinger, K. C., Sklar, C. A., Robison, L. L., & Mertens, A. C. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0555 · Cited by 288
Active and passive smoking and risk of breast cancer: a meta-analysis
Macacu, A., Autier, P., Boniol, M., & Boyle, P. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3628-4 · Cited by 256
Patients With Heart Failure Have an Increased Risk of Incident Cancer
Hasin, T., Gerber, Y., McNallan, S. M., Weston, S. A., Kushwaha, S. S., Nelson, T. J., Cerhan, J. R., & Roger, V. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.088 · Cited by 245
Ling, S., Brown, K., Miksza, J. K., Howells, L., Morrison, A., Issa, E., Yates, T., Khunti, K., Davies, M. J., & Zaccardi, F. (2020) · Diabetes Care · doi:10.2337/dc20-0204 · Cited by 241
Basic Biology of Oxidative Stress and the Cardiovascular System
Sack, M. N., Fyhrquist, F. Y., Saijonmaa, O. J., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.034 · Cited by 240
Incidence of Cancer in Patients with Chronic Heart Failure: A Long-Term Follow-Up Study
Banke, A., Schou, M., Videbæk, L., Møller, J. E., Torp-Pedersen, C., Gustafsson, F., Dahl, J. S., Køber, L., Hildebrandt, P. R., & Gislason, G. H. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.472 · Cited by 235
Fatal heart disease among cancer patients
Stoltzfus, K. C., Zhang, Y., Sturgeon, K., Sinoway, L. I., Trifiletti, D. M., Chinchilli, V. M., & Zaorsky, N. G. (2020) · Nature Communications · doi:10.1038/s41467-020-15639-5 · Cited by 235
Hypertension and breast cancer risk: a systematic review and meta-analysis
Han, H., Guo, W., Shi, W., Yu, Y., Zhang, Y., Ye, X., & He, J. (2017) · Scientific Reports · doi:10.1038/srep44877 · Cited by 231
Bergom, C., Bradley, J. A., Ng, A. K., Samson, P., Robinson, C., Lopez-Mattei, J., & Mitchell, J. D. (2021) · JACC: CardioOncology · doi:10.1016/j.jaccao.2021.06.007 · Cited by 230
Smoking and Colorectal Cancer Risk, Overall and by Molecular Subtypes: A Meta-Analysis
Botteri, E., Borroni, E., Sloan, E. K., Bagnardi, V., Bosetti, C., Peveri, G., Santucci, C., Specchia, C., van den Brandt, P., Gallus, S., et al. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000803 · Cited by 229
Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer
Hasin, T., Gerber, Y., Weston, S. A., Jiang, R., Killian, J. M., Manemann, S. M., Cerhan, J. R., & Roger, V. L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.04.053 · Cited by 227
Cancer and Heart Disease: Associations and Relations
de Boer, R. A., Meijers, W. C., van der Meer, P., & van Veldhuisen, D. J. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1539 · Cited by 227
Sitting Time and Risk of Cardiovascular Disease and Diabetes: A Systematic Review and Meta-Analysis
Bailey, D. P., Hewson, D. J., Champion, R. B., & Sayegh, S. M. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.04.015 · Cited by 216
Impact of multiple social determinants of health on incident stroke
Reshetnyak, E., Ntamatungiro, M., Pinheiro, L. C., Howard, V. J., Carson, A. P., Martin, K. D., & Safford, M. M. (2020) · Stroke · doi:10.1161/strokeaha.120.028530 · Cited by 214
Seretis, A., Cividini, S., Markozannes, G., Tseretopoulou, X., Lopez, D. S., Ntzani, E. E., & Tsilidis, K. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45014-4 · Cited by 209
Vascular toxic effects of cancer therapies
Herrmann, J. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0347-2 · Cited by 206
Immune Checkpoint Inhibitor Therapy in Oncology
Tan, S., Day, D., Nicholls, S. J., & Segelov, E. (2022) · JACC: CardioOncology · doi:10.1016/j.jaccao.2022.09.004 · Cited by 205
Thompson, A. S., Tresserra-Rimbau, A., Karavasiloglou, N., Jennings, A., Cantwell, M., Hill, C., Perez-Cornago, A., Bondonno, N. P., Murphy, N., Rohrmann, S., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.4714 · Cited by 203 · cited 2×
“In addition, a prospective cohort study using data from more than 100,000 participants from the UK Biobank showed that greater adherence to a healthy, plant-based diet was associated with a decreased risk of cancer (HR 0.93, 95% CI 0.88–0.99) and CVD (HR 0.92, 95% CI 0.86–0.99) 91 .”
InfluentialBlond, K., Brinkløv, C. F., Ried-Larsen, M., Crippa, A., & Grøntved, A. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2018-100393 · Cited by 201
The Role of Cardioprotection in Cancer Therapy Cardiotoxicity
Omland, T., Heck, S. L., & Gulati, G. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.01.101 · Cited by 200
Libby, P., & Kobold, S. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz058 · Cited by 197
Karam, G., Agarwal, A., Sadeghirad, B., Jalink, M., Hitchcock, C. L., Ge, L., Kiflen, R., Ahmed, W., Zea, A. M., Milenkovic, J., et al. (2023) · BMJ · doi:10.1136/bmj-2022-072003 · Cited by 192
Incident Cardiovascular Disease Among Adults With Cancer
Paterson, D. I., Wiebe, N., Cheung, W. Y., Mackey, J. R., Pituskin, E., Reiman, A., & Tonelli, M. (2022) · JACC: CardioOncology · doi:10.1016/j.jaccao.2022.01.100 · Cited by 191
A Mendelian randomization study of the effects of blood lipids on breast cancer risk
Nowak, C., & Ärnlöv, J. (2018) · Nature Communications · doi:10.1038/s41467-018-06467-9 · Cited by 190
Innate Immune Receptors: Key Regulators of Metabolic Disease Progression
Jin, C., Henao-Mejia, J., & Flavell, R. A. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.011 · Cited by 189
Understanding the role of the gut microbiome in gastrointestinal cancer: A review
Ağagündüz, D., Cocozza, E., Cemali, Ö., Bayazıt, A. D., Nanì, M. F., Cerqua, I., Morgillo, F., Saygılı, S. K., Berni Canani, R., Amero, P., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1130562 · Cited by 189
Cardiovascular Risk Factors Are Associated With Future Cancer
Lau, E. S., Paniagua, S. M., Liu, E., Jovani, M., Li, S. X., Takvorian, K., Suthahar, N., Cheng, S., Splansky, G. L., Januzzi, J. L., et al. (2021) · JACC: CardioOncology · doi:10.1016/j.jaccao.2020.12.003 · Cited by 185
Alcohol Consumption and Cardiovascular Disease: A Mendelian Randomization Study
Larsson, S. C., Burgess, S., Mason, A. M., & Michaëlsson, K. (2020) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.119.002814 · Cited by 183
de Boer, R. A., Hulot, J.-S., Tocchetti, C. G., Aboumsallem, J. P., Ameri, P., Anker, S. D., Bauersachs, J., Bertero, E., Coats, A. J. S., Čelutkienė, J., et al. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.2029 · Cited by 183
Clonal hematopoiesis and non-hematologic disorders
Jaiswal, S. (2020) · Blood · doi:10.1182/blood.2019000989 · Cited by 182
Late Cardiac Effects of Cancer Treatment
Lenihan, D. J., & Cardinale, D. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2938 · Cited by 178
Assessing and Addressing Social Determinants of Cardiovascular Health
Brandt, E. J., Tobb, K., Cambron, J. C., Ferdinand, K. C., Douglass, P., Nguyen, P. K. P., Vijayaraghavan, K., Islam, S., Thamman, R., Rahman, S., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.01.042 · Cited by 177
Dietary patterns and CVD: a systematic review and meta-analysis of observational studies
Rodríguez-Monforte, M., Flores-Mateo, G., & Sánchez, E. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515003177 · Cited by 176
Zhao, J., Stockwell, T., Roemer, A., Naimi, T., & Chikritzhs, T. (2017) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.375 · Cited by 173
Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
Aboumsallem, J. P., Moslehi, J., & de Boer, R. A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013754 · Cited by 173
Okwuosa, T. M., Morgans, A. K., Rhee, J., Reding, K. W., Maliski, S. L., Plana, J.-C., Volgman, A. S., Moseley, K. F., Porter, C., & Ismail-Khan, R. R. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000082 · Cited by 167
Risk of Cancer After Diagnosis of Cardiovascular Disease
Bell, C., Lei, X. J., Haas, A. M., Baylis, R. A., Gao, H., Luo, L., Giordano, S. H., Wehner, M. R., Nead, K. T., & Leeper, N. J. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.01.010 · Cited by 167
Risk of Atrial Fibrillation According to Cancer Type
Yun, J. P., Choi, E., Han, K., Park, S. H., Jung, J., Park, S. H., Ahn, H., Lim, J., Lee, S., & Oh, S. (2021) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.03.006 · Cited by 164
Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies
Yao, X., & Tian, Z. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0507-y · Cited by 153
Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
van Dorst, D. C. H., Dobbin, S. J. H., Neves, K. B., Herrmann, J., Herrmann, S. M., Versmissen, J., Mathijssen, R. H. J., Danser, A. H. J., & Lang, N. N. (2021) · Circulation Research · doi:10.1161/circresaha.121.318051 · Cited by 152
Hypertension in Cancer Patients and Survivors
Cohen, J. B., Geara, A. S., Hogan, J. J., & Townsend, R. R. (2019) · JACC CardioOncology · doi:10.1016/j.jaccao.2019.11.009 · Cited by 148
Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies
Georgiopoulos, G. A., Makris, N., Laina, A., Theodorakakou, F., Briasoulis, Α., Trougakos, I. P., Dimopoulos, M. A., Kastritis, E., & Stamatelopoulos, K. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.12.005 · Cited by 144
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies
Rahman, M. M., Islam, M. R., Shohag, S., Ahasan, M. T., Sarkar, N., Khan, H., Hasan, A. M., Cavalu, S. D., & Rauf, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112898 · Cited by 142
Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer
Karlstaedt, A., Moslehi, J. J., & de Boer, R. A. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00698-6 · Cited by 139
The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
Chakaroun, R., Olsson, L. M., & Bäckhed, F. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00771-0 · Cited by 139
Early Cardiac Remodeling Promotes Tumor Growth and Metastasis
Avraham, S., Abu-Sharki, S., Shofti, R., Haas, T., Korin, B., Kalfon, R., Friedman, T., Shiran, A., Saliba, W., Shaked, Y., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046471 · Cited by 135
Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia
Quartermaine, C., Ghazi, S. M., Yasin, A., Awan, F. T., Fradley, M. G., Wiczer, T. E., Kalathoor, S., Ferdousi, M., Krishan, S., Habib, A., et al. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.09.002 · Cited by 135
Quek, J., Lim, G., Lim, W. H., Ng, C. H., So, W. Z., Toh, J. Z. K., Pan, X. H., Chin, Y. H., Muthiah, M. D., Chan, S. P., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.756810 · Cited by 134
Serum Lipids and Breast Cancer Risk: A Meta-Analysis of Prospective Cohort Studies
Ni, H., Liu, H., & Gao, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142669 · Cited by 133
Alcohol drinking and all cancer mortality: a meta-analysis
Jin, M., Cai, S., Guo, J., Zhu, Y., Li, M., Yu, Y., Zhang, S., & Chen, K. (2012) · Annals of Oncology · doi:10.1093/annonc/mds508 · Cited by 126
Gan, Z. H., Cheong, H. C., Tu, Y.-K., & Kuo, P.-H. (2021) · Nutrients · doi:10.3390/nu13113952 · Cited by 125
Recent advances in modulation of cardiovascular diseases by the gut microbiota
Masenga, S. K., Hamooya, B., Hangoma, J., Hayumbu, V., Ertuglu, L. A., Ishimwe, J., Rahman, S., Saleem, M., Laffer, C. L., Elijovich, F., et al. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00698-6 · Cited by 121
Cardiometabolic Comorbidities in Cancer Survivors
Zullig, L. L., Sung, A. D., Khouri, M. G., Jazowski, S. A., Shah, N. P., Sitlinger, A. P., Blalock, D. V., Whitney, C. A., Kikuchi, R., Bosworth, H. B., et al. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.03.005 · Cited by 121
Pinheiro, L. C., Reshetnyak, E., Akinyemiju, T., Phillips, E., & Safford, M. M. (2022) · Cancer · doi:10.1002/cncr.33894 · Cited by 117
High density lipoprotein cholesterol and cancer: Marker or causative?
Pirro, M., Ricciuti, B., Rader, D. J., Catapano, A. L., Sahebkar, A., & Banach, M. (2018) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.06.001 · Cited by 116
Safford, M. M., Reshetnyak, E., Sterling, M. R., Richman, J. S., Muntner, P. M., Durant, R. W., Booth, J., & Pinheiro, L. C. (2021) · Circulation · doi:10.1161/circulationaha.120.048026 · Cited by 113
Handy, C. E., Quispe, R., Pintó, X., Blaha, M. J., Blumenthal, R. S., Michos, E. D., Lima, J. A. C., Güallar, E., Ryu, S., Cho, J., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035516 · Cited by 108
González-Jaramillo, N., Wilhelm, M., Arango-Rivas, A. M., González-Jaramillo, V., Mesa-Vieira, C., Minder, B., Franco, O. H., & Bano, A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.02.036 · Cited by 105
Miller, V., Micha, R., Choi, E., Karageorgou, D., Webb, P., & Mozaffarian, D. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.46705 · Cited by 103 · cited 2×
“Conversely, consuming processed meats, red meats and sugar-sweetened beverages increased the risk of CVD (RR range 1.06–1.15 per daily serving change for harmful associations) 86,87 .”
InfluentialAssociation Between Changes in Alcohol Consumption and Cancer Risk
Yoo, J. E., Han, K., Shin, D. W., Kim, D., Kim, B.-S., Chun, S., Jeon, K. H., Jung, W., Park, J., Park, J., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.28544 · Cited by 101
Ganatra, S., Dani, S. S., Kumar, A., Khan, S. U., Wadhera, R. K., Neilan, T. G., Thavendiranathan, P., Barac, A., Hermann, J., Leja, M. J., et al. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.06.005 · Cited by 98
Self-citationSterling, M. R., Ringel, J. B., Pinheiro, L. C., Safford, M. M., Levitan, E. B., Phillips, E., Brown, T. M., & Goyal, P. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014836 · Cited by 95
Sex-Specific Cardiovascular Risks of Cancer and Its Therapies
Wilcox, N. S., Rotz, S. J., Mullen, M., Song, E. J., Ky Hamilton, B., Moslehi, J., Armenian, S. H., Wu, J. C., Rhee, J.-W., & Ky, B. (2022) · Circulation Research · doi:10.1161/circresaha.121.319901 · Cited by 86 · cited 1×
“Imbalances in levels of endogenous sex hormones, as well as endocrine therapy for hormone-dependent malignancies such as breast and prostate cancer, are also associated with adverse cardiovascular sequelae 180,181 .”
Self-citationSerum lipid profiles and risk of colorectal cancer: a prospective cohort study in the UK Biobank
Fang, Z., He, M.-M., & Song, M. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01143-6 · Cited by 86
Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors
Glen, C., Tan, Y. Y., Waterston, A. M., Evans, T. R. J., Jones, R. J., Petrie, M. C., & Lang, N. N. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.01.096 · Cited by 86
The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis
Tian, Y., Wang, K., Li, J., Wang, J., Wang, Z., Fan, Y., Ye, Y., Ji, G., & Li, Y. (2015) · Public Health Nutrition · doi:10.1017/s1368980015000646 · Cited by 80
Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review
Arguelles, O. C., Jaiswal, S., Shlush, L. I., Moslehi, J. J., Schimmer, A. D., Barac, A., & Thavendiranathan, P. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0302 · Cited by 79
Preparing the Cardiovascular Workforce to Care for Oncology Patients
Hayek, S. S., Ganatra, S., Lenneman, C., Scherrer‐Crosbie, M., Leja, M. J., Lenihan, D. J., Yang, E. H., Ryan, T. D., Liu, J., Carver, J. R., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.041 · Cited by 79
Self-citationPrevalence of Cardiovascular Disease in Patients With Potentially Curable Malignancies
Battisti, N. M. L., Welch, C. A., Sweeting, M. J., de Belder, M., Deanfield, J. E., Weston, C. F. M., Peake, M. D., Adlam, D., & Ring, A. E. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.03.004 · Cited by 78
Lack of Association Between Heart Failure and Incident Cancer
Selvaraj, S., Bhatt, D. L., Claggett, B. L., Djoussé, L., Shah, S. J., Chen, J., Imran, T. F., Qazi, S., Sesso, H. D., Gaziano, J. M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.01.069 · Cited by 75
Pant, A., Gribbin, S., McIntyre, D., Trivedi, R., Marschner, S. L., Laranjo, L., Mamas, M. A., Flood, V. M., Chow, C. K., & Zaman, S. J. (2023) · Heart · doi:10.1136/heartjnl-2022-321930 · Cited by 67
HDL and cancer - causality still needs to be confirmed? Update 2020
Ganjali, S., Banach, M., Pirro, M., Fras, Z., & Sahebkar, A. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.007 · Cited by 65
Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations
Arguelles, O. C., Schöffel, A. C., Capo‐Chichi, J., Abdel-Qadir, H. M., Schuh, A. C., Estrada, M. C., Liu, S., Gupta, V. K., Schimmer, A. D., Yee, K. W. L., et al. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2021.11.008 · Cited by 64
Zhang, X., Pawlikowski, M., Olivo‐Marston, S., Williams, K. P., Bower, J. K., & Felix, A. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247919 · Cited by 61
Smoking and survival of breast cancer patients: A meta-analysis of cohort studies
Duan, W., Li, S., Xin, M., Sun, Y., & Jia, C. (2017) · The Breast · doi:10.1016/j.breast.2017.03.012 · Cited by 59
Incidence of cancers in patients with atherosclerotic cardiovascular diseases
Suzuki, M., Tomoike, H., Sumiyoshi, T., Nagatomo, Y., Hosoda, T., Nagayama, M., Ishikawa, Y., Sawa, T., Iimuro, S., Yoshikawa, T., et al. (2017) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2017.08.004 · Cited by 59
Harding, J. L., Sooriyakumaran, M., Anstey, K. J., Adams, R. J., Balkau, B., Brennan-Olsen, S. L., Briffa, T. G., Davis, T. M. E., Davis, W. A., Dobson, A. J., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000770 · Cited by 58
Karlstaedt, A., Barrett, M., Hu, R., Gammon, S. T., & Ky, B. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.05.008 · Cited by 51
Self-citationPriorities in Cardio-Oncology Basic and Translational Science
Salloum, F. N., Tocchetti, C. G., Ameri, P., Ardehali, H., Asnani, A. H., de Boer, R. A., Burridge, P. W., Cabrera, J. Á., de Castro, J., Córdoba, R., et al. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.08.003 · Cited by 49
Self-citationIncident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer
Raisi‐Estabragh, Z., Cooper, J. A., McCracken, C., Crosbie, E. J., Walter, F. M., Manisty, C., Robson, J. P., Mamas, M. A., Harvey, N. C., Neubauer, S., et al. (2023) · Heart · doi:10.1136/heartjnl-2022-321888 · Cited by 43
Leedy, D. J., Reding, K. W., Vasbinder, A. L., Anderson, G. L., Barac, A., Wactawski‐Wende, J., Shadyab, A. H., Eaton, C. B., Levy, W. C., Qi, L., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2207 · Cited by 42
Association of Cardiometabolic Disease With Cancer in the Community
Liu, E. E., Suthahar, N., Paniagua, S. M., Wang, D., Lau, E. S., Li, S. X., Jovani, M., Takvorian, K. S., Kreger, B. E., Benjamin, E. J., et al. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.01.095 · Cited by 40
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
Chianca, M., Panichella, G., Fabiani, I., Giannoni, A., L’Abbate, S., Aimo, A., Franco, A. D., Vergaro, G., Grigoratos, C., Castiglione, V., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.936654 · Cited by 36
Heart Failure Post-Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway
Tani, T., Oikawa, M., Misaka, T., Ishida, T., & Takeishi, Y. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.10.002 · Cited by 36
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies
Parashar, S., Akhter, N., Paplomata, E., Elgendy, I. Y., Upadhyaya, D., Scherrer‐Crosbie, M., Okwuosa, T. M., Sanghani, R. M., Chalas, E., Lindley, K. J., et al. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.02.002 · Cited by 30
Yuan, F., Wen, W., Jia, G., Long, J., Shu, X., & Zheng, W. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-1170 · Cited by 25
van Sloten, T. T., Valentin, E., Climie, R. E., Deraz, O., Weiderpass, E., Jouven, X., Goldberg, M., Zins, M., & Empana, J. P. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.11.015 · Cited by 24
Noyd, D. H., Liu, Q., Yasui, Y., Chow, E. J., Bhatia, S., Nathan, P. C., Landstrom, A. P., Tonorezos, E. S., Casillas, J., Berkman, A. M., et al. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.01.011 · Cited by 24
Stress Echocardiography Positivity Predicts Cancer Death
Carpeggiani, C., Landi, P., Michelassi, C., Andreassi, M. G., Sicari, R., & Picano, E. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007104 · Cited by 21
Cancer Immunotherapy Beyond Checkpoint Blockade
Welty, N. E., & Gill, S. I. (2022) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.11.006 · Cited by 21
Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors
Fuster, J. J. (2022) · Thrombosis Research · doi:10.1016/j.thromres.2021.12.009 · Cited by 15
Therapy-Related Clonal Hematopoiesis
Yura, Y., Cochran, J. D., & Walsh, K. X. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.02.010 · Cited by 15
Yang, H., Zeng, Y., Chen, W., Sun, Y., Hu, Y., Ying, Z., Wang, J., Qu, Y., Fang, F., Valdimarsdóttir, U. A., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01935-y · Cited by 7
Metadata
- Authors
- Wilcox, N. S., Amit, U., Reibel, J. B., Berlin, E., Howell, K., & Ky, B.
- Venue
- Nature Reviews Cardiology
- Published
- 2024-04-10
- Volume
- 21
- Issue
- 9
- Pages
- 617-631
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W4394692624
- Cited by
- 310
- References
- 181
- FWCI
- 25.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.